BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 8559479)

  • 1. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls.
    Hess B; Lippuner K; Takkinen R; Villiger L; Ackermann D; Jaeger P
    Nephrol Dial Transplant; 1995; 10(9):1614-9. PubMed ID: 8559479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.
    Pasch A; Frey FJ; Eisenberger U; Mohaupt MG; Bonny O
    Nephrol Dial Transplant; 2008 Aug; 23(8):2563-70. PubMed ID: 18398019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: role of protein intake.
    Hess B; Ackermann D; Essig M; Takkinen R; Jaeger P
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1916-21. PubMed ID: 7775641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hypophosphatemia in calcium nephrolithiasis.
    Yamakawa K; Kawamura J
    Mol Urol; 2000; 4(4):365-70. PubMed ID: 11156704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vertebral density of hypercalciuric lithiasis. Its relation to calcium-protein intake and vitamin D metabolism].
    Lalau JD; Achard JM; Bataille P; Bergot C; Jans I; Boudailliez B; Petit J; Henon G; Westeel PF; el Esper N
    Ann Med Interne (Paris); 1992; 143(5):293-8. PubMed ID: 1482031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ultraviolet B radiation treatments on calcium excretion and vitamin D metabolites in kidney stone formers.
    Varghese M; Rodman JS; Williams JJ; Brown A; Carter DM; Zerwekh JE; Pak CY
    Clin Nephrol; 1989 May; 31(5):225-31. PubMed ID: 2736812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dietary calcium on serum 1,25-dihydroxyvitamin D concentrations in renal stone formers.
    D'Amour P; Gascon-Barré M; Dufresne L; Perreault JP
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):549-62. PubMed ID: 6094046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic studies in kidney stone disease.
    Wong SY; Slater SR; Evans RA; Mason R; Lancaster EK; Acland SM; Eade Y; Hills E; Dunstan CR
    Q J Med; 1992 Mar; 82(299):247-58. PubMed ID: 1631259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal calcium conservation in recurrent stone-formers with idiopathic hypercalciuria.
    Goulding A; Hocken AG
    N Z Med J; 1985 Feb; 98(772):50-2. PubMed ID: 2983270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of absorptive hypercalciuria in tuberculosis patients.
    Martinez ME; Gonzalez J; Sanchez-Cabezudo MJ; Peña JM; Vazquez JJ; Felsenfeld A
    Calcif Tissue Int; 1993 Dec; 53(6):384-7. PubMed ID: 8293351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calcitriol and dietary protein intake in idiopathic calcium stone patients.
    Cupisti A; Morelli E; Meola M; Lenti C; Barsotti M; Palmieri D; Sposini S; Barsotti G
    Int J Clin Lab Res; 1999; 29(2):85-8. PubMed ID: 10436267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute PTH response to oral calcium load and seasonal variation of vitamin D status in healthy young adult subjects.
    Guillemant J; Guillemant S
    Eur J Clin Nutr; 1996 Jul; 50(7):469-72. PubMed ID: 8862484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.